openPR Logo
Press release

Rare Disease Treatment Market Estimated to exhibit a CAGR of 8.6% during 2017 – 2025

Rare Disease Treatment Market Estimated to exhibit a CAGR of 8.6%

A comprehensive evaluation presented by Persistence Market Research on the global rare disease treatment market in a new research report titled “Rare Disease Treatment Market: Global Industry Analysis 2012 – 2016 and Forecast 2017 – 2025” highlights the performance of the various segments in the market over a period of eight years. This involves the current scenario of the market dynamics along with the forecast of the entire market across various geographies. According to Persistence Market Research, there are many opportunities that promote revenue growth in this market during the forecast period.

Request to Sample of Report @ https://www.persistencemarketresearch.com/samples/12862

The report covers important geographies of North America, Latin America, Europe, Asia Pacific and Middle East and Africa. Of these major landscapes, North America lays a significant growth track to show a value of US$ 78,434 Mn by the end of 2025 according to forecast insights in the research study. Following North America, Europe and Asia Pacific, especially Japan, are in line showing potential for the treatment of rare diseases over the period of eight years. The Middle East and Africa region (MEA) will depict sluggish growth owing to low awareness of rare diseases and hence their treatments.

Several opportunities lurk around the market, creating a positive impact on global market growth rate

Acquisitions across the global scenario can be used to expand the business portfolio and operations of key players, who will do well to leverage this strategy to establish a global footprint. Forward integration can be achieved by expanding the value chain. The operating efficiency should be increased to achieve high return on investment. This can be achieved by shifting the manufacturing of important medicines to orphan drugs. The manufacturers of orphan drugs are enjoying the advantages of tax benefits, fast approvals and other research grants, thereby making room for more innovations. Product innovation can lead to advanced therapeutics and innovations in medicine or drugs, which can be used to tap new markets. Moreover, the increasing incidence of rare diseases gives a plus to the market. The public is aware of these rare diseases and this awareness is rising owing to government effort and other social groups. Adding to this scenario, the reimbursement schemes in developed economies are pushing the growth in demand for rare disease treatments and thereby fueling the rare disease treatment market growth in developed countries.

Global Rare Disease Treatment Market: Segmental Forecast

The global rare disease treatment market report involves a five level segmentation comprising – by therapeutic area, by drug type, by drug class, by mode of administration and by distribution channel.

The genetic diseases segment by therapeutic area, which was dominating the global market in the past will show similar traction in the next eight years. This segment is anticipated to be valued at US$ 56,241 Mn by the end of 2025. The metabolic diseases segment by therapeutic type shows higher growth rate as compared to the genetic disease segment and is poised to reach a value of US$ 23,938 Mn by 2025 end
By drug type, originator drugs is the largest segment in the global rare disease treatment market, estimated to hold about 75% market share by 2025 end
Of the various drug class segments, organic compounds is the dominant and most attractive segment, with attractiveness index of 0.6 during the forecast period
The oral segment by mode of administration dominates the global market for rare disease treatment from a revenue standpoint and is forecasted to continue this trait throughout the period of forecast. It has the highest market attractiveness index of 2.2. The injectable segment is poised to account for a value share of 39.5% by 2025 end and reflects a market attractiveness index of 0.8
By distribution channel, specialty pharmacies segment dominated the global rare disease treatment market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period. Specialty pharmacies is the most attractive segment, with attractiveness index of 1.6 during the forecast period

Request Report for TOC @ https://www.persistencemarketresearch.com/methodology/12862

Competitive Intelligence – Key Player Analysis

The research report on the global rare disease treatment market profiles key players in the market and their complete intelligence including facts such as product portfolio, strategies, geographical spread, etc. Some of the key players involved are Novartis AG, Pfizer, F. Hoffmann-La Roche Ltd., Celgene Corporation, AbbVie Inc., Johnson & Johnson Services, Inc., Shire, Alexion, Novo Nordisk A/S, Sanofi, Bayer AG, Amgen, Inc., Allergan plc., Eisai Co. Ltd., Bristol-Myers Squibb Company, Merck & Co., Inc., Vertex Pharmaceuticals, Baxter, BioMarin and Teva Pharmaceutical Industries Ltd.

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rare Disease Treatment Market Estimated to exhibit a CAGR of 8.6% during 2017 – 2025 here

News-ID: 1138276 • Views: 265

More Releases from Persistence Market Research Pvt.Ltd.

Dental Restoration Market Present Scenario and the Growth Prospects 2017 - 2025
The term dental restoration covers an integrated management of oral health and restoring the oral health to a functional and esthetic state. The American Dental Association has not considered restorative dentist as a separate specialty though the dentists are able to perform man of these procedures without any additional course or certification. The dental restoration procedures depend on how difficult the procedure is and what the professional feels comfortable with.
Mobile Air Transfer Systems Market Trends and Key Developments 2017 - 2025
Mobile air transfer system is the system used in hospitals and other medical centers that helps to reduce patient handling injury. The system provides patients with simple and comfortable transfer experience along with significantly reducing the cumulative handling effect of thousands of pounds of patients’ weight while routine transfers. To ensure the safety of hundreds of millions of people suffering from health care associated infections and abnormalities mobile air transfer
Orthopedic Veterinary Implants Market is projected to reach US$ 3,500 Mn by 2026
Arthritis is a common disorder which has been recently seen spreading its roots dogs. At present, this diseases is treated with the help of orthopedic veterinary implants. The global orthopedic veterinary implants market has witnessed a substantial surge in the last couple years owing to the rise in pet adoption and their orthopedic surgeries. Majority of the population, especially in the developed regions, own pets such as cats or dogs.
Prepackaged Medical Kits and Trays Market is anticipated to Register a CAGR of 8 …
There has been a Herculean shift in the healthcare industry towards a reformed model and significant rise in investments worldwide is intended to improve various facilities and services across the healthcare industry. The concept of value-based pricing of pharmaceuticals has gained momentum in the last few years and a majority of the OECD countries have adopted this model. This shift has been a crucial component for the revenue growth of

All 5 Releases


More Releases for Rare

Global Rare Hematology Market
https://www.qandqmarketresearch.com/report-sample/rare-hematology2018-market-70 The Global and Chinese Rare Hematology Industry, 20132023 Market Research Report is a professional and indepth study on the current state of the global Rare Hematology industry with a focus on the Chinese market. The report provides key statistics on the market status of the Rare Hematology manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic
Global Rare Earth Metals Market 2017 - Beifang Rare Earth, Xiamen Tungsten, Sunl …
Rare Earth Metals Market 2017 Industry research report provides important information to identify and analyze the market need, market size and competition. This market research report used in maintaining competitiveness over competitors. Scope of the Report: This report focuses on the Rare Earth Metals in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Global Rare Earth Metals Market 2017 - Sunlux Rare Metal, Beifang Rare Earth, Ji …
Global Rare Earth Metals Industry 2017 report introduced size, share, trends, conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth, SWOT analysis, investment feasibility analysis, and investment return analysis etc. Global Rare Earth Metals Industry is an accurate and quality research study on the Global Rare Earth Metals market. This report is based on the briefings and interviews conducted with product manufacturers and their consumers,
Global Rare Earth Metals Market 2017- Beifang Rare Earth, Jiangtong Rare Earth, …
Global Rare Earth Metals Industry 2017 is a comprehensive, professional report delivering market research data that is relevant for new market entrants or established players. Key strategies of the companies operating in the market and their impact analysis have been included in the report. Furthermore, a business overview, revenue share, and SWOT analysis of the leading players in the Rare Earth Metals market is available in the report. Download Sample Report
RARE 24k Therapy Creme
Introducing Rare 24k Therapy: When NSAIDS, toxic pain killers, chiropractors and heating pads aren’t giving you enough, add RARE 24K Therapy Crème to your doctor prescribed regime. A new, natural, and scientifically proven, gold skincare remedy that delivers non-toxic pain relief to people suffering with arthritis, muscle strains, or joint pain. Press Release – December 2016 SALT LAKE CITY - RARE, 24k Gold Therapy Crème offers deep therapeutic relief using newly
Rare Books Auction - Biblical Rarities
Hamburg, 04 September, 2014 (kk) – It is nothing less than one of the most important German early woodcut books. Now the printed German edition of the “Neunte Deutsche Bibel”, the only one by Anton Koberger, godfather of Albrecht Dürer, will be sold in the auction of Rare Books at Ketterer Kunst in Hamburg on 17/18 November. The remarkably well-preserved copy from 1483 was executed in a pleasing new type.